CrushSCI.com
121.5Average days
101Median days
11Fastest days
388Longest days
3012025 publications

Paper Review Records

All Paper Review Records

17 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

79 days

Stakeholder-informed use cases and target product characteristics for vaccines and therapeutics for Nipah virus disease

Authors
Md Zakiul Hassan; Stacey Wooden; Leyanna Susan George; Melissa Malhame; Mariann Vaule Bringsværd; Pragya Yadav; Rubina Bose; Amanda Rojek; Peter Horby; Richard G. Jarman; Nivedita Gupta; Piero OlliaroShow moreShow less
Affiliations
1. ISARIC, Pandemic Sciences Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK; 2. icddr, b, Dhaka, Bangladesh; 3. Coalition for Epidemic Preparedness Innovation (CEPI), Oslo, Norway; 4. Indian Council of Medical Research, New Delhi, IndiaShow moreShow less
Source PDF DOI Publisher page
246 days

RTS,S-induced off-target antibody responses in malaria-naïve adults associated with protection against controlled human malaria infection

Authors
DeAnna J. Friedman-Klabanoff; Travis L. Jensen; Casey E. Gelber; Brandon D. Hoenig; Olukemi O. Ifeonu; Richard Pinapati; John C. Tan; Gregory A. Deye; Jason A. Regules; Elke S. Bergmann-Leitner; Matthew B. Laurens; Mark A. Travassos; Johannes B. Goll; Shannon Takala-Harrison; Andrea A. BerryShow moreShow less
Affiliations
1. Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, USA; 2. Ryan White Center for Pediatric Infectious Diseases and Global Health, Department of Pediatrics, Indiana University School of Medicine, Indianapolis, USA; 3. Bioinformatics and Data Science Department, The Emmes Company LLC, Rockville, USA; 4. Institute for Genome Sciences, University of Maryland School of Medicine, Baltimore, USA; 5. Nimble Therapeutics, Inc., Madison, USA; 6. Parasitology and International Programs Branch, Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, USA; 7. AstraZeneca, Gaithersburg, USA; 8. Walter Reed Army Institute of Research, Silver Spring, USA; 9. United States Army Medical Research Institute of Infectious Diseases, Frederick, USAShow moreShow less
Source PDF DOI Publisher page
101 days

Linear cap-independent mRNA vaccines as an emerging vaccine platform

Authors
Ziqi Chen; Hongwu Yu; Shenglin HuangShow moreShow less
Affiliations
1. Department of Integrative Oncology, Fudan University Shanghai Cancer Center, and Shanghai Key Laboratory of Medical Epigenetics, Institutes of Biomedical Sciences, Fudan University, Shanghai, China; 2. School of Basic Medical Sciences, Shanghai Medical College, Fudan University, Shanghai, China; 3. Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China; 4. State Key Laboratory of Genetics and Development of Complex Phenotypes, Fudan University, Shanghai, ChinaShow moreShow less
Source PDF DOI Publisher page
121 days

SARS-CoV-2 breakthrough infections imprint signatures of enhanced immunity against COVID-19

Authors
Davide Proietto; Beatrice Dallan; Mara Martino; Martina De Laurentis; Enrico Tassani; Eleonora Gallerani; Sara Ghisellini; Amedeo Zurlo; Stefano Volpato; Benedetta Govoni; Anna Casabianca; Chiara Orlandi; Valentina Albanese; Sian Llewellyn-Lacey; Salvatore Pacifico; Simona Semprini; Vittorio Sambri; Helen M. Parry; Paul A. H. Moss; Kristin Ladell; David A. Price; Elena Torreggiani; Antonella Caputo; Riccardo Gavioli; Francesco NicoliShow moreShow less
Affiliations
1. Department of Environmental and Prevention Sciences, University of Ferrara, Ferrara, Italy; 2. Department of Chemical, Pharmaceutical and Agricultural Sciences, University of Ferrara, Ferrara, Italy; 3. Laboratory of Clinical Pathology, University Hospital St. Anna, Ferrara, Italy; 4. Department of Medical Sciences, University of Ferrara, Geriatrics Unit, University Hospital of Ferrara, Ferrara, Italy; 5. Department of Pure and Applied Sciences, Section of Chemistry, Environment and Materials, University of Urbino Carlo Bo, Fano, Italy; 6. Laboratorio Covid, University of Urbino Carlo Bo, Fano, Italy; 7. Department of Biomolecular Sciences, Section of Biochemistry and Biotechnology, University of Urbino Carlo Bo, Fano, Italy; 8. Division of Infection and Immunity, Cardiff University School of Medicine, University Hospital of Wales, Cardiff, UK; 9. Unit of Microbiology, Greater Romagna Area Hub Laboratory, Cesena, Italy; 10. Department of Medical and Surgical Sciences, Alma Mater Studiorum, University of Bologna, Bologna, Italy; 11. College of Medicine and Health, University of Birmingham, Birmingham, UK; 12. Systems Immunity Research Institute, Cardiff University School of Medicine, University Hospital of Wales, Cardiff, UK; 13. Department of Translational Medicine, University of Ferrara, Ferrara, ItalyShow moreShow less
Source PDF DOI Publisher page
100 days

Coordinated serum interferon gamma and IL-15 responses to PfRAS vaccination are associated with protection from malaria

Authors
Fergal J. Duffy; Anton Götz; Sean T. Windle; Nana Minkah; John D. Aitchison; Suzanne M. McDermott; Kenneth D. StuartShow moreShow less
Affiliations
1. Center for Global Infectious Disease Research, Seattle Children’s Research Institute, Seattle, USA; 2. Department of Pediatrics, University of Washington School of Medicine, Seattle, USAShow moreShow less
Source PDF DOI Publisher page
128 days

A structure-guided trivalent subunit vaccine confers maternal protection to neonatal piglets against PEDV and PDCoV

Authors
Jia Liu; Longping Chen; Dan Li; Zhuo Wang; Bo Wang; Chun Peng; Long Ma; Yongqiang Zhao; Yating Wang; Tiegang Bai; Dongni Yang; Enqi DuShow moreShow less
Affiliations
1. College of Veterinary Medicine, Northwest A&F University, Yangling, China; 2. Yangling Carey Biological Sci-tech Co. Ltd., Yangling, China; 3. Chengdu Nano-Biologicals Co. Ltd., Chengdu, ChinaShow moreShow less
Source PDF DOI Publisher page

FAQ

How long does npj Vaccines take to review a manuscript?

As of 2026-11-18, CrushSCI has 17 complete review records for npj Vaccines. The fastest paper went from submission to acceptance in 11 days (Vaccinology in the twenty-first century revisited, received 2026-07-13, accepted 2026-07-24); the slowest took 388 days. The average is 121.5 days and the median is 101 days.

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

We will reply within 30 minutes.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review59.6 days

Median65 days

Contact CrushSCI

Contact CrushSCI

Leave your email address to discuss academic polishing, structural refinement, or one-to-one guidance.

We will reply within 30 minutes.

Selected service: Academic Consulting Service

Leave your email address

Or email us directly at leader@crushsci.com

Enter your email address so we can reply. Your details will remain private.